We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.20 | -0.25% | 79.75 | 80.345 | 79.165 | 79.92 | 7,012,074 | 00:12:32 |
From Jun 2023 to Jun 2024
By Will Feuer
Medtronic raised its full-year outlook for sales and adjusted earnings after the medical-device maker reported fiscal second quarter results that topped Wall Street analysts' expectations.
The company is now targeting fiscal-year organic revenue growth of 4.75%, up from 4.5%. Including the anticipated impact from currency fluctuations and other revenue, Medtronic said it anticipated organic growth of 2.6%.
The company also increased its fiscal-year adjusted earnings outlook to $5.13 a share to $5.19 a share, up from a prior range of $5.08 a share to $5.16 a share.
Chief Financial Officer Karen Parkhill cited the company's second-quarter performance and updated estimates for the impact of taxes and foreign currency on fiscal-year results in raising guidance.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
November 21, 2023 07:27 ET (12:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
